{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:08:20Z","timestamp":1782623300350,"version":"3.54.5"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5K08HL132012 and 5K08HL129074"],"award-info":[{"award-number":["5K08HL132012 and 5K08HL129074"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11906-018-0887-6","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T07:09:41Z","timestamp":1534230581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mineralocorticoids and Cardiovascular Disease in Females with Insulin Resistance and Obesity"],"prefix":"10.1007","volume":"20","author":[{"given":"Manav","family":"Nayyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Lastra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Manrique","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"issue":"12","key":"887_CR1","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.2337\/dc06-1537","volume":"30","author":"EL Air","year":"2007","unstructured":"Air EL, Kissela BM. Diabetes, the metabolic syndrome, and ischemic stroke: epidemiology and possible mechanisms. Diabetes Care. 2007;30(12):3131\u201340.","journal-title":"Diabetes Care"},{"key":"887_CR2","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1038\/ijo.2008.31","volume":"32","author":"CM Ballantyne","year":"2008","unstructured":"Ballantyne CM, Hoogeveen RC, McNeill AM, Heiss G, Schmidt MI, Duncan BB, et al. Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int J Obes. 2008;32:S21\u20134.","journal-title":"Int J Obes"},{"issue":"10","key":"887_CR3","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.114.014796","volume":"132","author":"MA Cavender","year":"2015","unstructured":"Cavender MA, Steg PG, Smith SC Jr, Eagle K, Ohman EM, Goto S, et al. Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Circulation. 2015;132(10):923\u201331.","journal-title":"Circulation"},{"issue":"14","key":"887_CR4","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.114.013797","volume":"132","author":"J George","year":"2015","unstructured":"George J, Rapsomaniki E, Pujades-Rodriguez M, Shah AD, Denaxas S, Herrett E, et al. How does cardiovascular disease first present in women and men? Incidence of 12 cardiovascular diseases in a contemporary cohort of 1,937,360 people. Circulation. 2015;132(14):1320\u20138.","journal-title":"Circulation"},{"issue":"21","key":"887_CR5","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1001\/jama.2016.6458","volume":"315","author":"KM Flegal","year":"2016","unstructured":"Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. Jama. 2016;315(21):2284\u201391.","journal-title":"Jama"},{"key":"887_CR6","doi-asserted-by":"crossref","unstructured":"Gregg, E.W. et al. Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985\u20132011: a modelling study. Lancet Diabetes Endocrinol 2014.","DOI":"10.1016\/S2213-8587(14)70161-5"},{"issue":"12","key":"887_CR7","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1161\/CIRCULATIONAHA.106.658948","volume":"115","author":"CS Fox","year":"2007","unstructured":"Fox CS, Coady S, Sorlie PD, D\u2019Agostino RB, Pencina MJ, Vasan RS, et al. Increasing cardiovascular disease burden due to diabetes mellitus. The Framingham Heart Study. 2007;115(12):1544\u201350.","journal-title":"The Framingham Heart Study"},{"issue":"4","key":"887_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/07853899608999089","volume":"28","author":"TJ Orchard","year":"1996","unstructured":"Orchard TJ. The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Ann Med. 1996;28(4):323\u201333.","journal-title":"Ann Med"},{"issue":"7","key":"887_CR9","doi-asserted-by":"publisher","first-page":"962","DOI":"10.2337\/diacare.23.7.962","volume":"23","author":"WL Lee","year":"2000","unstructured":"Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care. 2000;23(7):962\u20138.","journal-title":"Diabetes Care"},{"issue":"11","key":"887_CR10","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1210\/jc.2007-1088","volume":"92","author":"R Bentley-Lewis","year":"2007","unstructured":"Bentley-Lewis R, Adler GK, Perlstein T, Seely EW, Hopkins PN, Williams GH, et al. Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab. 2007;92(11):4472\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"887_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/j.1550-8528.1999.tb00418.x","volume":"7","author":"TL Goodfriend","year":"1999","unstructured":"Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res. 1999;7(4):355\u201362.","journal-title":"Obes Res"},{"issue":"1","key":"887_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/HYPERTENSIONAHA.114.03936","volume":"65","author":"A Buglioni","year":"2015","unstructured":"Buglioni A, Cannone V, Cataliotti A, Sangaralingham SJ, Heublein DM, Scott CG, et al. Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease. Hypertension. 2015;65(1):45\u201353.","journal-title":"Hypertension"},{"issue":"16","key":"887_CR13","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1056\/NEJM198104163041602","volume":"304","author":"ML Tuck","year":"1981","unstructured":"Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med. 1981;304(16):930\u20133.","journal-title":"N Engl J Med"},{"issue":"8","key":"887_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0002-9149(86)90845-3","volume":"57","author":"AP Rocchini","year":"1986","unstructured":"Rocchini AP, Katch VL, Grekin R, Moorehead C, Anderson J. Role for aldosterone in blood pressure regulation of obese adolescents. Am J Cardiol. 1986;57(8):613\u20138.","journal-title":"Am J Cardiol"},{"issue":"12 Pt 2","key":"887_CR15","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1097\/00004872-199816121-00032","volume":"16","author":"GP Rossi","year":"1998","unstructured":"Rossi GP, Sacchetto A, Pavan E, Scognamiglio R, Pietra M, Pessina C. Left ventricular systolic function in primary aldosteronism and hypertension. J Hypertens. 1998;16(12 Pt 2):2075\u20137.","journal-title":"J Hypertens"},{"issue":"4","key":"887_CR16","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1210\/jc.2009-2521","volume":"95","author":"R Garg","year":"2010","unstructured":"Garg R, Hurwitz S, Williams GH, Hopkins PN, Adler GK. Aldosterone production and insulin resistance in healthy adults. J Clin Endocrinol Metab. 2010;95(4):1986\u201390.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"887_CR17","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1210\/jc.2006-0736","volume":"91","author":"C Catena","year":"2006","unstructured":"Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Novello M, et al. Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J Clin Endocrinol Metab. 2006;91(9):3457\u201363.","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"887_CR18","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.2174\/0929867324666170710121145","volume":"24","author":"F Santilli","year":"2017","unstructured":"Santilli F, D'Ardes D, Guagnano MT, Davi G. Metabolic syndrome: sex-related cardiovascular risk and therapeutic approach. Curr Med Chem. 2017;24(24):2602\u201327.","journal-title":"Curr Med Chem"},{"issue":"1","key":"887_CR19","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1152\/ajpregu.00185.2016","volume":"313","author":"MO Murphy","year":"2017","unstructured":"Murphy MO, Loria AS. Sex-specific effects of stress on metabolic and cardiovascular disease: are women at higher risk? Am J Physiol Regul Integr Comp Physiol. 2017;313(1):R1\u2013r9.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"887_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.phrs.2017.03.008","volume":"120","author":"G Pucci","year":"2017","unstructured":"Pucci G, Alcidi R, Tap L, Battista F, Mattace-Raso F, Schillaci G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature. Pharmacol Res. 2017;120:34\u201342.","journal-title":"Pharmacol Res"},{"issue":"4","key":"887_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/oxfordjournals.aje.a113654","volume":"118","author":"E Barrett-Connor","year":"1983","unstructured":"Barrett-Connor E, Wingard DL. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol. 1983;118(4):489\u201396.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"887_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archinte.1995.00430010063008","volume":"155","author":"WB Kannel","year":"1995","unstructured":"Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med. 1995;155(1):57\u201361.","journal-title":"Arch Intern Med"},{"issue":"9","key":"887_CR23","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.2337\/dc12-1272","volume":"36","author":"MM Roche","year":"2013","unstructured":"Roche MM, Wang PP. Sex differences in all-cause and cardiovascular mortality, hospitalization for individuals with and without diabetes, and patients with diabetes diagnosed early and late. Diabetes Care. 2013;36(9):2582\u201390.","journal-title":"Diabetes Care"},{"issue":"1","key":"887_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.115.06054","volume":"67","author":"N Ayuzawa","year":"2016","unstructured":"Ayuzawa N, Nagase M, Ueda K, Nishimoto M, Kawarazaki W, Marumo T, et al. Rac1-mediated activation of mineralocorticoid receptor in pressure overload\u2013induced cardiac injury. Hypertension. 2016;67(1):99\u2013106.","journal-title":"Hypertension"},{"issue":"14","key":"887_CR25","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1001\/archinte.161.14.1717","volume":"161","author":"FB Hu","year":"2001","unstructured":"Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001;161(14):1717\u201323.","journal-title":"Arch Intern Med"},{"issue":"6","key":"887_CR26","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1210\/jc.2003-030490","volume":"88","author":"JS Williams","year":"2003","unstructured":"Williams JS, Williams GH. 50th anniversary of aldosterone. J Clin Endocrinol Metab. 2003;88(6):2364\u201372.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"887_CR27","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/1440-1681.12125","volume":"40","author":"BK V","year":"2013","unstructured":"V BK, McCurley A, Jaffe IZ. Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation. Clin Exp Pharmacol Physiol. 2013;40(12):902\u20139.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"887_CR28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.coph.2015.02.004","volume":"21","author":"A Tarjus","year":"2015","unstructured":"Tarjus A, Amador C, Michea L, Jaisser F. Vascular mineralocorticoid receptor and blood pressure regulation. Curr Opin Pharmacol. 2015;21:138\u201344.","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"887_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1161\/01.CIR.92.2.175","volume":"92","author":"M Lomb\u00e8s","year":"1995","unstructured":"Lomb\u00e8s M, et al. Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11\u03b2-hydroxysteroid dehydrogenase in the human heart. Circulation. 1995;92(2):175\u201382.","journal-title":"Circulation"},{"issue":"4812","key":"887_CR30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1126\/science.3037703","volume":"237","author":"J Arriza","year":"1987","unstructured":"Arriza J, Weinberger C, Cerelli G, Glaser T, Handelin B, Housman D, et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 1987;237(4812):268\u201375.","journal-title":"Science"},{"issue":"4878","key":"887_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1126\/science.2845584","volume":"242","author":"J Funder","year":"1988","unstructured":"Funder J, Pearce P, Smith R, Smith A. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1988;242(4878):583\u20135.","journal-title":"Science"},{"issue":"6","key":"887_CR32","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","volume":"96","author":"IZ Jaffe","year":"2005","unstructured":"Jaffe IZ, Mendelsohn ME. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res. 2005;96(6):643\u201350.","journal-title":"Circ Res"},{"issue":"8","key":"887_CR33","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1161\/ATVBAHA.111.229070","volume":"31","author":"BG Newfell","year":"2011","unstructured":"Newfell BG, Iyer LK, Mohammad NN, McGraw AP, Ehsan A, Rosano G, et al. Aldosterone regulates vascular gene transcription via oxidative stress\u2013dependent and \u2013independent pathways. Arterioscler Thromb Vasc Biol. 2011;31(8):1871\u201380.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"887_CR34","doi-asserted-by":"publisher","first-page":"T67","DOI":"10.1530\/JOE-17-0009","volume":"234","author":"JJ DuPont","year":"2017","unstructured":"\u2022\u2022 DuPont JJ, Jaffe IZ. 30 Years of the mineralocorticoid receptor: the role of the mineralocorticoid receptor in the vasculature. J Endocrinol. 2017;234(1):T67\u2013t82. Comprehensive review of the action of MR activation in the vasculature.","journal-title":"J Endocrinol"},{"issue":"4","key":"887_CR35","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1096\/fj.15-271254","volume":"30","author":"M Bretschneider","year":"2016","unstructured":"Bretschneider M, Busch B, Mueller D, Nolze A, Schreier B, Gekle M, et al. Activated mineralocorticoid receptor regulates micro-RNA-29b in vascular smooth muscle cells. FASEB J. 2016;30(4):1610\u201322.","journal-title":"FASEB J"},{"issue":"2","key":"887_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","volume":"37","author":"A Fiebeler","year":"2001","unstructured":"Fiebeler A, Schmidt F, Muller DN, Park JK, Dechend R, Bieringer M, et al. Mineralocorticoid receptor affects AP-1 and nuclear factor-\u03baB activation in angiotensin II\u2013induced cardiac injury. Hypertension. 2001;37(2):787\u201393.","journal-title":"Hypertension"},{"key":"887_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.physiol.70.113006.100518","volume":"70","author":"ER Prossnitz","year":"2008","unstructured":"Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol. 2008;70:165\u201390.","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"887_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/CIRCRESAHA.108.190892","volume":"104","author":"E Haas","year":"2009","unstructured":"Haas E, Bhattacharya I, Brailoiu E, Damjanovic M, Brailoiu GC, Gao X, et al. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res. 2009;104(3):288\u201391.","journal-title":"Circ Res"},{"issue":"2","key":"887_CR39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1161\/HYPERTENSIONAHA.111.184606","volume":"59","author":"MR Meyer","year":"2012","unstructured":"Meyer MR, Amann K, Field AS, Hu C, Hathaway HJ, Kanagy NL, et al. Deletion of G protein\u2013coupled estrogen receptor increases endothelial vasoconstriction. Hypertension. 2012;59(2):507\u201312.","journal-title":"Hypertension"},{"issue":"13\u201314","key":"887_CR40","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.lfs.2012.01.007","volume":"91","author":"MR Meyer","year":"2012","unstructured":"Meyer MR, Field AS, Kanagy NL, Barton M, Prossnitz ER. GPER regulates endothelin-dependent vascular tone and intracellular calcium. Life Sci. 2012;91(13\u201314):623\u20137.","journal-title":"Life Sci"},{"issue":"3","key":"887_CR41","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.110.161653","volume":"57","author":"R Gros","year":"2011","unstructured":"Gros R, Ding Q, Sklar LA, Prossnitz EE, Arterburn JB, Chorazyczewski J, et al. GPR30 expression is required for the mineralocorticoid receptor\u2013independent rapid vascular effects of aldosterone. Hypertension. 2011;57(3):442\u201351.","journal-title":"Hypertension"},{"issue":"6","key":"887_CR42","doi-asserted-by":"publisher","first-page":"C532","DOI":"10.1152\/ajpcell.00203.2012","volume":"304","author":"R Gros","year":"2013","unstructured":"Gros R, Ding Q, Liu B, Chorazyczewski J, Feldman RD. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am J Physiol Cell Physiol. 2013;304(6):C532\u201340.","journal-title":"Am J Physiol Cell Physiol"},{"key":"887_CR43","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics\u20142017 Update: a report from the American Heart Association. Circulation. 2017;135:e146\u2013603.","journal-title":"Circulation"},{"issue":"3","key":"887_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0002-9149(70)90796-4","volume":"26","author":"H Selye","year":"1970","unstructured":"Selye H. The evolution of the stress concept. Stress and cardiovascular disease. Am J Cardiol. 1970;26(3):289\u201399.","journal-title":"Am J Cardiol"},{"issue":"10","key":"887_CR45","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341(10):709\u201317.","journal-title":"N Engl J Med"},{"issue":"49","key":"887_CR46","first-page":"2073","volume":"89","author":"D Fuster","year":"2000","unstructured":"Fuster D, Frey FJ, Ferrari P. Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure. Praxis (Bern 1994). 2000;89(49):2073\u20136.","journal-title":"Praxis (Bern 1994)"},{"issue":"6","key":"887_CR47","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ahj.2004.10.005","volume":"148","author":"KP Tamirisa","year":"2004","unstructured":"Tamirisa KP, Aaronson KD, Koelling TM. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure. Am Heart J. 2004;148(6):971\u20138.","journal-title":"Am Heart J"},{"issue":"8481","key":"887_CR48","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0140-6736(86)92856-4","volume":"1","author":"G Bellati","year":"1986","unstructured":"Bellati G, Ideo G. Gynaecomastia after spironolactone and potassium canrenoate. Lancet. 1986;1(8481):626.","journal-title":"Lancet"},{"issue":"1","key":"887_CR49","first-page":"10","volume":"151","author":"FC Hugues","year":"2000","unstructured":"Hugues FC, Gourlot C, Le Jeunne C. Drug-induced gynecomastia. Ann Med Interne (Paris). 2000;151(1):10\u20137.","journal-title":"Ann Med Interne (Paris)"},{"issue":"5 Suppl","key":"887_CR50","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1067\/mhj.2002.129970","volume":"144","author":"MA Weber","year":"2002","unstructured":"Weber MA. Clinical implications of aldosterone blockade. Am Heart J. 2002;144(5 Suppl):S12\u20138.","journal-title":"Am Heart J"},{"issue":"14","key":"887_CR51","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348(14):1309\u201321.","journal-title":"N Engl J Med"},{"issue":"15","key":"887_CR52","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"SA Hunt","year":"2009","unstructured":"Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53(15):e1\u2013e90.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"887_CR53","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey de Jr, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147\u2013239.","journal-title":"J Am Coll Cardiol"},{"key":"887_CR54","doi-asserted-by":"crossref","unstructured":"Cooper LB, et al. Use of mineralocorticoid receptor antagonists in patients with heart failure and comorbid diabetes mellitus or chronic kidney disease. J Am Heart Assoc. 2017;6(12)","DOI":"10.1161\/JAHA.117.006540"},{"issue":"Suppl 1","key":"887_CR55","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.nephro.2017.02.003","volume":"13","author":"LM Ruilope","year":"2017","unstructured":"Ruilope LM, Tamargo J. Renin-angiotensin system blockade: finerenone. Nephrol Ther. 2017;13(Suppl 1):S47\u2013s53.","journal-title":"Nephrol Ther"},{"issue":"1","key":"887_CR56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/FJC.0000000000000091","volume":"64","author":"P Kolkhof","year":"2014","unstructured":"Kolkhof P, Delbeck M, Kretschmer A, Steinke W, Hartmann E, B\u00e4rfacker L, et al. Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury. J Cardiovasc Pharmacol. 2014;64(1):69\u201378.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"887_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/FJC.0000000000000366","volume":"67","author":"J Grune","year":"2016","unstructured":"Grune J, Benz V, Brix S, Salatzki J, Blumrich A, H\u00f6ft B, et al. Steroidal and nonsteroidal mineralocorticoid receptor antagonists cause differential cardiac gene expression in pressure overload-induced cardiac hypertrophy. J Cardiovasc Pharmacol. 2016;67(5):402\u201311.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"887_CR58","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1161\/HYPERTENSIONAHA.117.10360","volume":"71","author":"J Grune","year":"2018","unstructured":"\u2022 Grune J, et al. Selective mineralocorticoid receptor cofactor modulation as molecular basis for finerenon\u2019s antifibrotic activity. Hypertension. 2018;71(4):599\u2013608. This investigation examines the antifibrotic role of finerenone in a rodent model of heart failure via inhibition of TNX expression.","journal-title":"Hypertension"},{"issue":"8","key":"887_CR59","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/cmdc.201200081","volume":"7","author":"L Barfacker","year":"2012","unstructured":"Barfacker L, et al. Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases. ChemMedChem. 2012;7(8):1385\u2013403.","journal-title":"ChemMedChem"},{"issue":"31","key":"887_CR60","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1093\/eurheartj\/eht187","volume":"34","author":"B Pitt","year":"2013","unstructured":"Pitt B, Kober L, Ponikowski P, Gheorghiade M, Filippatos G, Krum H, et al. Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial. Eur Heart J. 2013;34(31):2453\u201363.","journal-title":"Eur Heart J"},{"issue":"27","key":"887_CR61","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1093\/eurheartj\/ehw132","volume":"37","author":"G Filippatos","year":"2016","unstructured":"Filippatos G, Anker SD, B\u00f6hm M, Gheorghiade M, K\u00f8ber L, Krum H, et al. A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and\/or chronic kidney disease. Eur Heart J. 2016;37(27):2105\u201314.","journal-title":"Eur Heart J"},{"issue":"2","key":"887_CR62","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/ndt\/gft409","volume":"29","author":"F Hammer","year":"2014","unstructured":"Hammer F, Krane V, Stork S, Roser C, Hofmann K, Pollak N, et al. Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa). Nephrol Dial Transplant. 2014;29(2):400\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"887_CR63","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cyto.2018.04.024","volume":"110","author":"LR Lopes","year":"2018","unstructured":"Lopes LR, Ribeiro SMLT, Figueiredo VP, Leite ALJ, Nicolato RLC, Gomes JAE, et al. The overweight increases circulating inflammatory mediators commonly associated with obesity in young individuals. Cytokine. 2018;110:169\u201373.","journal-title":"Cytokine"},{"issue":"5 Pt 1","key":"887_CR64","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.amjhyper.2004.12.005","volume":"18","author":"S Kathiresan","year":"2005","unstructured":"Kathiresan S, et al. Clinical and genetic correlates of serum aldosterone in the community: the Framingham heart study. Am J Hypertens. 2005;18(5 Pt 1):657\u201365.","journal-title":"Am J Hypertens"},{"issue":"3","key":"887_CR65","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/01.HYP.0000154361.47683.d3","volume":"45","author":"S Engeli","year":"2005","unstructured":"Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension. 2005;45(3):356\u201362.","journal-title":"Hypertension"},{"key":"887_CR66","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1161\/HYPERTENSIONAHA.117.11087","volume":"71","author":"MZ Shukri","year":"2018","unstructured":"Shukri MZ, Tan JW, Manosroi W, Pojoga LH, Rivera A, Williams JS, et al. Biological sex modulates the adrenal and blood pressure responses to angiotensin II. Hypertension. 2018;71:1083\u201390.","journal-title":"Hypertension"},{"issue":"5","key":"887_CR67","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1161\/HYPERTENSIONAHA.114.04912","volume":"65","author":"SB Bender","year":"2015","unstructured":"Bender SB, DeMarco VG, Padilla J, Jenkins NT, Habibi J, Garro M, et al. Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction. Hypertension. 2015;65(5):1082\u20138.","journal-title":"Hypertension"},{"issue":"5","key":"887_CR68","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","volume":"59","author":"AM Briones","year":"2012","unstructured":"Briones AM, et al. Adipocytes produce aldosterone through calcineurin-dependent signaling pathways. Implications in Diabetes Mellitus\u2013Associated Obesity and Vascular Dysfunction. Hypertension. 2012;59(5):1069\u201378.","journal-title":"Hypertension"},{"issue":"22","key":"887_CR69","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","volume":"132","author":"A-C Huby","year":"2015","unstructured":"\u2022\u2022 Huby A-C, et al. Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis. Circulation. 2015;132(22):2134\u201345. This investigation elegantly dsecribes how leptin regulates aldosterone synthesis and how leptin-mediated increased aldosterone secretion results in endothelial dysfunction and cardiac fibrosis.","journal-title":"Circulation"},{"issue":"5","key":"887_CR70","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1161\/HYPERTENSIONAHA.115.06642","volume":"67","author":"AC Huby","year":"2016","unstructured":"\u2022 Huby AC, Otvos L Jr, Belin de Chantemele EJ. Leptin induces hypertension and endothelial dysfunction via aldosterone-dependent mechanisms in obese female mice. Hypertension. 2016;67(5):1020\u20138. The investigation shows that that leptin results in hypertension and endothelial dysfunction via aldosterone-dependent mechanisms in obese female mice.","journal-title":"Hypertension"},{"issue":"1","key":"887_CR71","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.115.05674","volume":"66","author":"VG DeMarco","year":"2015","unstructured":"DeMarco VG, Habibi J, Jia G, Aroor AR, Ramirez-Perez FI, Martinez-Lemus LA, et al. Low-dose mineralocorticoid receptor blockade prevents Western diet-induced arterial stiffening in female mice. Hypertension. 2015;66(1):99\u2013107.","journal-title":"Hypertension"},{"key":"887_CR72","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1161\/CIRCRESAHA.115.308269","volume":"118","author":"G Jia","year":"2016","unstructured":"Jia G, Habibi J, Aroor AR, Martinez-Lemus LA, DeMarco VG, Ramirez-Perez FI, et al. Endothelial mineralocorticoid receptor mediates diet induced aortic stiffness in females. Circ Res. 2016;118:935\u201343.","journal-title":"Circ Res"},{"issue":"10","key":"887_CR73","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1210\/en.2013-1256","volume":"154","author":"C Manrique","year":"2013","unstructured":"Manrique C, DeMarco VG, Aroor AR, Mugerfeld I, Garro M, Habibi J, et al. Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet. Endocrinology. 2013;154(10):3632\u201342.","journal-title":"Endocrinology"},{"issue":"9","key":"887_CR74","doi-asserted-by":"publisher","first-page":"H1126","DOI":"10.1152\/ajpheart.00898.2014","volume":"308","author":"B Bostick","year":"2015","unstructured":"Bostick B, Habibi J, DeMarco VG, Jia G, Domeier TL, Lambert MD, et al. Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice. Am J Physiol Heart Circ Physiol. 2015;308(9):H1126\u201335.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"887_CR75","doi-asserted-by":"publisher","first-page":"e007675","DOI":"10.1161\/JAHA.117.007675","volume":"7","author":"AP Davel","year":"2018","unstructured":"\u2022\u2022 Davel AP, et al. Sex-specific mechanisms of resistance vessel endothelial dysfunction induced by cardiometabolic risk factors. J Am Heart Assoc. 2018;7(4):e007675. This paper examines the differential role of endothelial cell mineralocortidoid receptor activation in the genesis of endothelial dysfunction in obese and hyperlipidemic female mice when compared with males.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"887_CR76","doi-asserted-by":"publisher","first-page":"e007675","DOI":"10.1161\/JAHA.117.007675","volume":"7","author":"Ana P. Davel","year":"2018","unstructured":"Davel AP, et al. Sex-specific mechanisms of resistance vessel endothelial dysfunction induced by cardiometabolic risk factors. J Am Heart Assoc. 2018;7(4)","journal-title":"Journal of the American Heart Association"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-018-0887-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-018-0887-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-018-0887-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T16:57:50Z","timestamp":1589734670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-018-0887-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1007\/s11906-018-0887-6","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"assertion":[{"value":"14 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethics Standards"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"88"}}